Therapeutic Asset Ratings
204 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dalzanemdor
Alzheimer Disease
Supernus Pharmaceuticals, Inc.
P2
CCC
(54)
Daoib
Alzheimer Disease
Chang Gung Memorial Hospital
P2
CCC
(54)
LEUPROLIDE
Alzheimer Disease
Weill Medical College of Cornell University
P2
CCC
(54)
Marijuana
Alzheimer Disease
Federal University of Latin American Integration
P2
CCC
(54)
Rapamycin
Alzheimer Disease
Karolinska Institutet
P2
CCC
(54)
HISTIDINE
Alzheimer Disease
Wake Forest University Health Sciences
P4
CCC
(53)
VAROGLUTAMSTAT
Alzheimer Disease
Vivoryon Therapeutics N.V.
P2
CCC
(53)
acd856
Alzheimer Disease
AlzeCure Pharma
P1
CCC
(53)
[18F]Flornaptitril
Alzheimer Disease
CereMark Pharma, LLC
P3
CCC
(52)
FLORQUINITAU
Alzheimer Disease
Sinotau Pharmaceutical Group
P3
CCC
(52)
IMMUNOGLOBULIN G1, ANTI-(HUMAN 1-40-.BETA.-AMYLOID/HUMAN 1-42-.BETA.-AMYLOID) (HUMAN MONOCLONAL .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL .KAPPA.-CHAIN, DIMER
Alzheimer Disease
Hoffmann-La Roche
P3
CCC
(52)
Karx-Ec
Alzheimer Disease
Bristol-Myers Squibb
P3
CCC
(52)
Karxt
Alzheimer Disease
Bristol-Myers Squibb
P3
CCC
(52)
Maltodextrin
Alzheimer Disease
ScandiBio Therapeutics AB
P3
CCC
(52)
Nilotinib Be
Alzheimer Disease
KeifeRx, LLC
P3
CCC
(52)
Xanomeline Enteric
Alzheimer Disease
Bristol-Myers Squibb
P3
CCC
(52)
bey2153
Alzheimer Disease
BeyondBio Inc.
P2
CCC
(52)
Hmscs
Alzheimer Disease
Bernard (Barry) Baumel
P2
CCC
(52)
Igc Ad1
Alzheimer Disease
IGC Pharma, LLC
P2
CCC
(52)
mk-2214
Alzheimer Disease
Merck Sharp & Dohme LLC
P2
CCC
(52)
Ntrx-07
Alzheimer Disease
NeuroTherapia, Inc.
P2
CCC
(52)
Rb-Adsc
Alzheimer Disease
Regeneration Biomedical, Inc.
P2
CCC
(52)
Sabirnetug
Alzheimer Disease
Acumen Pharmaceuticals
P2
CCC
(52)
TACROLIMUS
Alzheimer Disease
Second Affiliated Hospital of Nanchang University
P2
CCC
(52)
((3AR,6AS)-5-(4,6-DIMETHYLPYRIMIDIN- 2-YL)HEXAHYDROPYRROLO(3,4-C)PYRROL-2(1H)-YL)(2-FLUORO- 6-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE OREXIN RECEPTOR ANTAGONIST
Alzheimer Disease
Janssen Research & Development, LLC
P2
CCC
(51)
Showing 51 to 75 of 204 assets
Previous
Page 3 of 9
Next